Based on the information available, it is generally recommended to avoid live vaccines for up to 6 months after taking Cosentyx (secukinumab) [1]. Cosentyx is a medication used to treat several conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It belongs to a class of drugs known as monoclonal antibodies, which work by targeting and blocking a specific protein in the body that contributes to inflammation [1].

Live vaccines contain weakened forms of live viruses or bacteria, and they work by stimulating an immune response in the body [2]. If a live vaccine is given while taking Cosentyx, there is a risk that the vaccine may not be as effective, or there may be an increased risk of infection [2]. Therefore, it is important to discuss any planned vaccinations with a healthcare provider before receiving them [1].

It is also important to note that not all vaccines are live vaccines. Inactivated vaccines, which contain killed viruses or bacteria, and subunit, recombinant, polysaccharide, and conjugate vaccines, which contain specific parts of viruses or bacteria, are not live vaccines and can generally be given safely while taking Cosentyx [2].

In summary, based on the available information, it is recommended to avoid live vaccines for up to 6 months after taking Cosentyx [1]. However, it is always best to consult with a healthcare provider for personalized medical advice.

Sources:
[1] DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab). Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>
[2] Centers for Disease Control and Prevention. (2021, February 12). Vaccine Information for Healthcare Providers. Retrieved from <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html>